CTSO

$4.54+10.19%visit website

Cytosorbents Corp

Market Cap

$285M

Live price × SEC shares (Jul 31, 2026)

Sector

Health Care

Industry

Health Care

Beta (raw)

1.47

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

7.7

TTM to Jun 2026 · revenue

P/B

N/M

TTM to Jun 2026 · negative equity

EV/EBITDA (TTM)

N/M

TTM to Jun 2026 · negative EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	9,485	9,234	8,864	9,633	37,216
Cost of revenue	2,819	2,430	2,734	2,584	10,567
Gross profit	6,666	6,804	6,130	7,049	26,649
Research & development			1,025	1,453
Selling, general & administrative	8,610	9,436	8,149	7,964	34,159
Total operating expenses	9,528	11,189	9,174	9,687	39,578
Operating income	(2,862)	(4,385)	(3,044)	(2,638)	(12,929)
Pretax income	(3,571)	(5,497)
Income tax	(401)	0	0	0	(401)
Net income	(3,170)	(5,497)	(5,129)	(4,417)	(18,213)
EPS (basic) ($)	(0.05)		(0.08)	(0.07)	(0.29)
EPS (diluted) ($)	(0.05)		(0.08)	(0.07)	(0.29)
Weighted avg. shares (basic)	62,754		62,739	62,807
Weighted avg. shares (diluted)	62,754		62,739	62,807

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 6, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

11 filings in 12 months · 2 with priority itemsFull history →

Filed	Items	Filing
Sep 23, 2026 accepted 7:30 AM ET	7.01Reg FD disclosure8.01Other events	Document SEC ↗
Sep 8, 2026 accepted 4:05 PM ET	5.03Bylaws / fiscal year	Document SEC ↗
Aug 14, 2026 accepted 4:05 PM ET	5.07Shareholder vote	Document SEC ↗
Aug 7, 2026 accepted 4:06 PM ET	7.01Reg FD disclosure	Document SEC ↗
Aug 6, 2026 accepted 4:19 PM ET	2.02Earnings release	Document SEC ↗
Jul 6, 2026 accepted 4:05 PM ET	3.01Delisting notice	Document SEC ↗
Jun 25, 2026 accepted 9:26 AM ET	7.01Reg FD disclosure	Document SEC ↗
May 13, 2026 accepted 4:05 PM ET	2.02Earnings release	Document SEC ↗
Apr 2, 2026 accepted 7:00 AM ET	3.01Delisting notice	Document SEC ↗
Mar 25, 2026 accepted 4:27 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

80%

W/W +49.1pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Velocity Score

4.02x

Avg Daily Buying (90d)

2,315 sh/day

Baseline Daily Buying

1,475 sh/day

Unique Buyers (90d)

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-09-15	2026-09-16	Sobel Alan D.	Director	Purchase	2,500	$6.10	$15K	9,887	View
2026-09-15	2026-09-16	Chan Phillip P.	Director & Chief Executive Officer	Purchase	3,774	$6.00	$23K	101.0K	View
2026-09-14	2026-09-16	Capponi Vincent	President and COO	Purchase	2,073	$6.05	$13K	40.4K	View
2026-09-04	2026-09-09	Chan Phillip P.	Director & Chief Executive Officer	Purchase	200.0K	$0.35	$70K	1.94M	View
2026-06-15	2026-06-16	MARIANI PETER J	Chief Financial Officer	Purchase	100.0K	$0.44	$44K	638.1K	View

1–5 of 7

1 / 2

Recent News

CytoSorbents to Report Third Quarter 2026 Financial Results and Recent Business Highlights

Yahoo · 2026-10-29

A live Q&A follows CytoSorbents' third-quarter results on Nov. 12.

Stock Titan · 2026-10-29

12 Health Care Stocks Moving In Friday's After-Market Session

Benzinga · 2026-10-23

WBB Securities Initiates Coverage On CytoSorbents with Speculative Buy Rating, Announces Price Target of $9.5

Benzinga · 2026-10-21

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Benzinga · 2026-10-21

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga · 2026-10-19

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga · 2026-10-16

CytoSorbents Announces New Data Presentations at Upcoming International Conferences in Cardiac Surgery and Critical Care

Yahoo Finance · 2026-09-30

Cytosorbents (CTSO) CEO adds to stake in open-market buy

Stock Titan · 2026-09-16

CytoSorbents to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Yahoo Finance · 2026-09-10

CytoSorbents to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference

Yahoo Finance · 2026-09-04

CTSO: CytoSorbents Announces Very Positive New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor

Yahoo Finance · 2026-09-03

CytoSorbents Announces Reverse Stock Split

PR Newswire · 2026-09-03

CytoSorbents Announces New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor and Updates Recent DrugSorb-ATR FDA Pre-Submission Meetings

Yahoo Finance · 2026-09-02

$CTSO stock is up 19% today. Here's what we see in our data.

Quiver Quantitative · 2026-09-02

Informational purposes only, not investment advice.

CTSO

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

Cytosorbents Corp (CTSO)

Reporting Insiders

Factor Profile

Corporate Events (8-K)

Date	Insider	Type	Shares	Value
2026-09-15	Sobel Alan D.	P	100	$601
2026-09-15	Chan Phillip P.	P	3,774	$22,644
2026-09-15	Sobel Alan D.	P	500	$3,025
2026-09-15	Sobel Alan D.	P	1,900	$11,628
2026-09-14	Capponi Vincent	P	273	$1,610.7